Abstract
There is randomised study evidence that narrowband ultraviolet B (NB-UVB) is effective for eczema. A small controlled study did not detect an efficacy difference between bath 8-MOP PUVA (psoralen drug with the main effects limited to the skin as the drug is 'activated' there by ultraviolet A [UVA] exposure) and NB-UVB. Another small randomised study showed that 5-MOP oral PUVA worked better than medium-dose ultraviolet A1 (UVA1). A systematic review concluded that NB-UVB and ultraviolet A1 were the most effective phototherapies for eczema and pointed out the limited comparative evidence regarding PUVA.
Original language | English |
---|---|
Pages (from-to) | 153-156 |
Number of pages | 4 |
Journal | Photodermatology, Photoimmunology & Photomedicine |
Volume | 37 |
Issue number | 2 |
Early online date | 23 Sept 2020 |
DOIs | |
Publication status | Published - Mar 2021 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Radiology Nuclear Medicine and imaging
- Dermatology